Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
about
Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical PracticeReliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimens.Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan.IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin.Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate ImmunityAntiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.Impact of HCV genetic differences on pathobiology of disease.Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.Hepatitis C variability, patterns of resistance, and impact on therapyHepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.Structural evaluation of the peritubular sheath of rat's testes after administration of ribavirin: A possible impact on the testicular function.Quasispecies and Drug Resistance
P2860
Q27490447-C18FABB9-A2FC-47F4-8E61-996967BDFB6DQ35906682-22ACC329-30A3-4B6F-977A-405D9F2A3FD3Q36142763-475490EE-4317-494E-8C31-616E650E0243Q36949481-2DF7C81B-13C9-434F-87DE-557832EB26E0Q37208481-36E5157A-E0CF-4C51-97F9-163AD294C662Q37263865-B56BBFD7-6275-41C8-8B93-456B8C493A93Q37929753-0A764E0F-6D72-4F82-9077-6348DE90D7B1Q37996076-9787EA86-47BA-494C-A934-3875A05E12E3Q39576325-CED10E8E-07E8-497E-8C68-D03819328FE1Q42270437-0214BF72-709A-4332-A208-573D730823C6Q46198512-6DB8AAA7-4A93-49CB-83DE-74F658B1A0C2Q56957250-B8BE5ED2-D4B7-4F9A-8D6C-268115148C8D
P2860
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@ast
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@en
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@nl
type
label
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@ast
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@en
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@nl
prefLabel
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@ast
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@en
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@nl
P2860
P356
P1476
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
@en
P2093
Jean-Michel Pawlotsky
P2860
P304
P356
10.1177/1756283X09336045
P577
2009-07-01T00:00:00Z